Boundless Bio, Inc. Common Stock (BOLD) — Financial Flexibility Index
Boundless Bio, Inc. Common Stock (BOLD) has a Financial Flexibility Index of -0.17x as of September 2025. Free cash flow of $-10.18 Million (operating CF $-10.20 Million minus capex $15.00K) represents 0% of total liabilities ($58.55 Million). Check Boundless Bio, Inc. Common Stock tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Boundless Bio, Inc. Common Stock Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Boundless Bio, Inc. Common Stock across 7 annual periods. For the full cash flow conversion analysis, see Boundless Bio, Inc. Common Stock cash flow conversion.
Annual Financial Flexibility Index for Boundless Bio, Inc. Common Stock (2016–2024)
Year-by-year free cash flow to debt coverage for Boundless Bio, Inc. Common Stock. Explore Boundless Bio, Inc. Common Stock (BOLD) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.05x | $-58.30 Million | $-60.84 Million | $55.77 Million | ▼ -481.3% |
| 2023 | -0.18x | $-46.22 Million | $-46.85 Million | $256.98 Million | ▲ +26.0% |
| 2022 | -0.24x | $-38.53 Million | $-39.60 Million | $158.53 Million | ▼ -74.0% |
| 2021 | -0.14x | $-21.21 Million | $-23.25 Million | $151.91 Million | ▲ +95.7% |
| 2018 | -3.23x | $-96.37 Million | $-107.98 Million | $29.80 Million | ▲ +7.3% |
| 2017 | -3.49x | $-76.96 Million | $-84.51 Million | $22.06 Million | ▼ -144.5% |
| 2016 | -1.43x | $-32.37 Million | $-49.02 Million | $22.69 Million | — |